Company intelligence / Profile preview
BiocurePharm
South Koreabiocure.co.kr ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Other
01
Overview
BiocurePharm is a Korean biopharmaceutical company developing biosimilars and novel biologics, including drugs for solid cancers leveraging angiogenesis-related approaches; available public data indicate mostly pre-clinical and early development activities with no approved products yet.[1][2][4][5]
- Therapeutic areas
- OncologyImmunology
- Modalities
- BiologicProteinRecombinant proteinVaccine
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborations with several medical schools and hospitals in Korea (names not specified)[1]
Beyond the preview
Go deeper on BiocurePharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BiocurePharm.